Skip to main content

Praxis Precision Medicines, Inc (PRAX) Stock

Praxis Precision Medicines, Inc Stock Details, Movements and Public Alerts

Stock Details

Praxis Precision Medicines, Inc (PRAX), a prominent company in the healthcare sector within the biotechnology industry, is based in United States and primarily trades on the NMS.Currently, the stock is trading at $387.30. Over the past 52 weeks, it has ranged between $37.19 and $392.70. This places the current price at 98.6% of its 52-week high and 941.4% above its 52-week low. 0The 14-day Relative Strength Index (RSI) stands at 56.44, suggesting neutral conditions. The stock is currently trading above its 50-day moving average of $321.21 by 20.58%. Similarly, it is above its 200-day moving average of $297.81 by 30.05%. The MACD histogram is 2.33, indicating bullish momentum (MACD Line: 16.56, Signal Line: 14.23).

52-Week Range

$392.70 - $37.19

-1.38% from high · +941.41% from low

Avg Daily Volume

442,788

20-day average

100-day avg: 463,205

Fundamentals

Valuation Metrics

P/E Ratio (TTM)

N/A

Forward P/E

-39.23

Price to Book

7.59

EV/EBITDA

-24.92

EPS (TTM)

-$12.98

Beta

2.78

More volatile than market

Q:How is PRAX valued relative to its earnings and growth?
Valuation data is not available for this stock.
Q:What is PRAX's risk profile compared to the market?
With a beta of 2.78, Praxis Precision Medicines, Inc is significantly more volatile than the market. For every 10% market move, this stock tends to move 28% in the same direction. Higher beta stocks offer greater potential returns but with increased risk. The price-to-book ratio of 7.59 shows investors value the company above its book value, which often reflects intangible assets or growth prospects.

Performance & Growth

Profit Margin

0.00%

Operating Margin

0.00%

EBITDA

$-378,048,000

Return on Equity

-38.86%

Return on Assets

-25.65%

Q:How profitable and efficient is PRAX's business model?
Profitability metrics are not available for this stock.
Q:What are PRAX's recent growth trends?
Growth data is not available for this stock.

Company Size & Market

Market Cap

$10.2B

Shares Outstanding

27.92M

Book Value/Share

$48.04

Asset Type

EQUITY

Q:What is PRAX's market capitalization and position?
Praxis Precision Medicines, Inc has a market capitalization of $10.2B, classifying it as a large-cap stock ($10B-$200B). Large-caps are typically industry leaders with established business models, offering a balance of stability and growth potential. They often provide dividend income and are core holdings in institutional portfolios. With 27.92M shares outstanding, the company's ownership is relatively concentrated. As a participant in the Biotechnology industry, it competes with other firms in this sector.
Q:How does PRAX's price compare to its book value?
Praxis Precision Medicines, Inc's book value per share is $48.04, while the current stock price is $387.30, resulting in a price-to-book (P/B) ratio of 8.06. This high P/B ratio indicates significant intangible assets, strong brand value, or high growth expectations. Technology and consumer brand companies often trade at elevated P/B ratios due to intellectual property and competitive advantages not reflected on the balance sheet. As EQUITY, this represents a specific type of security.

Analyst Ratings

Analyst Target Price

$638.68

64.91% upside potential

Analyst Recommendations

Strong Buy

2

Buy

12

Hold

0

Sell

1

Strong Sell

0

Q:How reliable are analyst predictions for PRAX?
15 analysts cover PRAX with 93% recommending buy/strong buy ratings. Analyst predictions have mixed reliability - studies show consensus rarely beats market returns consistently. The strong bullish consensus may already be priced in. The consensus target of $638.68 implies 64.9% upside, but targets are often adjusted to follow price moves rather than predict them.
Q:What is the Wall Street consensus on PRAX?
Current analyst recommendations:2 Strong Buy, 12 Buy, 01 Sell, 0The bullish tilt suggests optimism about future prospects, though investors should conduct independent research.Remember that analyst opinions often lag price movements and can be influenced by investment banking relationships.

Fundamentals last updated: Aug 21, 2026, 02:02 AM

Technical Indicators

RSI (14-day)

56.44

Neutral

50-Day Moving Average

$321.21

20.58% above MA-50

200-Day Moving Average

$297.81

30.05% above MA-200

MACD Line

16.56

MACD Signal

14.23

MACD Histogram

2.33

Bullish

Q:What does PRAX's RSI value tell investors?
The RSI (Relative Strength Index) for PRAX is currently 56.44, indicating the stock is in neutral territory (40-60 range). Neither buyers nor sellers have clear control, suggesting consolidation or balanced market forces. Combined with the price being above the 50-day moving average, this confirms bullish conditions.
Q:How should traders interpret PRAX's MACD and moving average crossovers?
MACD analysis shows the MACD line at 16.56 above the signal line at 14.23, with histogram at 2.33. This bullish crossover suggests upward momentum is building. The wide histogram confirms strong momentum. The 50-day MA ($321.21) is above the 200-day MA ($297.81), forming a golden cross pattern that typically signals a long-term uptrend. Price is currently above both MAs, confirming strength.

Indicators last updated: Aug 21, 2026, 11:46 AM

Active Alerts

No active alerts for this stock.

Be the first to set up an alert for PRAX and get notified when the price changes.

Stay Ahead of the Market with Praxis Precision Medicines, Inc Alerts

Set up price alerts for Praxis Precision Medicines, Inc and get notified instantly when the price hits your target. Never miss an important price movement again.